{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360013172004225152.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.bbamem.2017.01.037"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0005273617300457?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0005273617300457?httpAccept=text/plain"}}],"dc:title":[{"@value":"LL-37-derived membrane-active FK-13 analogs possessing cell selectivity, anti-biofilm activity and synergy with chloramphenicol and anti-inflammatory activity"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380013172004225280","@type":"Researcher","foaf:name":[{"@value":"Ganesan Rajasekaran"}]},{"@id":"https://cir.nii.ac.jp/crid/1380013172004225281","@type":"Researcher","foaf:name":[{"@value":"Eun Young Kim"}]},{"@id":"https://cir.nii.ac.jp/crid/1380013172004225282","@type":"Researcher","foaf:name":[{"@value":"Song Yub Shin"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00052736"}],"prism:publicationName":[{"@value":"Biochimica et Biophysica Acta (BBA) - Biomembranes"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2017-05","prism:volume":"1859","prism:number":"5","prism:startingPage":"722","prism:endingPage":"733"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","http://www.elsevier.com/open-access/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0005273617300457?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0005273617300457?httpAccept=text/plain"}],"createdAt":"2017-02-02","modifiedAt":"2024-06-22","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360294643740216576","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Targeted Delivery of Miconazole Employing LL37 Fragment Mutant Peptide CKR12-Poly (Lactic-Co-Glycolic) Acid Polymeric Micelles"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.bbamem.2017.01.037"},{"@type":"CROSSREF","@value":"10.3390/ijms222112056_references_DOI_Wdoqgel3tZ3QzbAoXi1EnvlRpqG"}]}